Categories: Health

Optinose Announces Departure of Acting Chief Financial

Published by
Globe News Wire

YARDLEY, Pa., Dec. 09, 2022 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Michele Janis, Acting Chief Financial Officer, will leave Optinose to accept a CFO opportunity at a privately-held company. Ms. Janis will continue to serve as Acting Chief Financial Officer until her departure on December 30, 2022.

Chief Executive Officer Peter Miller stated “On behalf of our entire team, I would like to express our deep appreciation to Michele for her commitment and contributions to Optinose where she has been a valuable and trusted partner for over 11 years. Michele was instrumental in building the finance and accounting functions from the ground up and leading the Company’s transition from a privately held development stage to a publicly held commercial stage company. We wish Michele continued success in her new role.”

Anthony Krick, Vice President, Controller, will continue to serve as Vice President and Chief Accounting Officer and be responsible for financial reporting and managing the day to-day activities of the finance & accounting team. Jonathan Neely, Vice President, Investor Relations & Business Development will continue to lead investor communications. Mr. Krick and Mr. Neely will both continue to serve on the Company’s leadership team.

“It’s been a privilege to have played a key role in the evolution of Optinose and to have been part of an exceptionally talented team over the past 11+ years,” said Michele Janis, departing Acting Chief Financial Officer.

About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S. To learn more, please visit or follow us on Twitter and LinkedIn.

Optinose Investor Contact
Jonathan Neely

Globe News Wire
Published by
Globe News Wire

Recent Posts

IPG Photonics Launches Three High-Power Deep Ultraviolet

OXFORD, Mass., Jan. 30, 2023 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (Nasdaq: IPGP), the world… Read More

57 mins ago

Avicanna Announces Warrant and Debenture Repricing and


58 mins ago

Catalight Care Services Professionals Convene to Learn and Discuss Social Determinants of Health, Person-Centered Care and other Top Priorities

Fourth annual Enhancing Your Impact continuing education conference addressed improving the care experience for individuals… Read More

1 hour ago

Novotech Awarded by Frost & Sullivan for Global Biotech Clinical Trials Excellence in APAC

With a proven biotech market leadership position, Novotech's compelling value proposition drives its sustained success… Read More

2 hours ago

NXP Semiconductors Reports Fourth Quarter and Full-Year

EINDHOVEN, The Netherlands, Jan. 30, 2023 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI) today… Read More

2 hours ago

Half-Year Report of Liquidity Contract with Crédit

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland) January 30, 2023 – GENFIT (Nasdaq and… Read More

2 hours ago